论文部分内容阅读
目的观察氯雷他定治疗儿童支气管哮喘的临床疗效。方法观察本院诊治的76例支气管哮喘患儿为研究对象,随机分为两组,A组38例,进行常规治疗,B组38例,加用氯雷他定口服。观察两组患者住院期间症状和体征消失时间和6个月内复发率。结果 A组患者住院期间症状和体征消失时间和6个月内复发率均高于B组,P<0.05,差异有统计学意义。结论氯雷他定对于儿童支气管哮喘有很好的预防和治疗效果。
Objective To observe the clinical efficacy of loratadine in children with bronchial asthma. Methods A total of 76 patients with bronchial asthma treated by our hospital were enrolled in this study. They were randomly divided into two groups. Group A (n = 38) received routine treatment. Group B (n = 38) received oral loratadine. During the hospital stay, the disappearance of symptoms and signs and the relapse rate within 6 months were observed. Results The duration of disappearance of symptoms and signs and the recurrence rate within 6 months during hospitalization in group A were significantly higher than those in group B (P <0.05). The difference was statistically significant. Conclusion Loratadine has good preventive and therapeutic effects on bronchial asthma in children.